Literature DB >> 21353876

Intracrine signaling mechanisms of activin A and TGF-β.

Olav A Gressner1.   

Abstract

While autocrine stimulation of cells by Activin A and/or its family member transforming growth factor β (TGF-β) is a phenomenon observed in a variety of cell types, little is known of putative intracellular signaling loops of these cytokines. Intracellular actions of several peptide hormones, growth factors, as well as of extracellular signaling enzymes and DNA-binding proteins, either within target cells or within their cells of synthesis have been shown. Although these intracrine moieties are structurally diverse, they share certain characteristics of synthesis and function. Depending on the cell type, there are reports of stimulatory as well as inhibitory mechanisms induced by such intracrine mechanisms, and this also accounts for transforming growth factor β (TGF-β), whereas only stimulatory intracrine signaling of Activin A could be demonstrated so far. Stimulatory intracrine signaling loops of TGF-β were shown following calpain-dependent intracellular proteolytic activation of the latent cytokine in hepatocytes under cellular stress conditions of this cytokine, leading to transcriptional activation of connective tissue growth factor (CTGF/CCN2) as a representative TGF-β-sensitive reporter gene. In contrast to TGF-β, increasing intrahepatocellular concentrations of Activin A are not the result of release from an intracellularly deposited latent complex, but of active de novo synthesis. The stimulatory intracrine signaling pathways of both, TGF-β and Activin A, are proposed to occur via Alk4/Alk5 receptors and Smad2, whereas additional activation of Smad3 only seems to be involved in intracrine Activin A signaling. However, intracrine TGF-β signaling may itself also be inhibitory as active TGF-β is also able to bind to intracellular TGF-β type II receptor, resulting in a ligand-induced impediment in receptor trafficking to the cell surface. Whether stimulatory or inhibitory modulation of the TGF-β pathway takes place seems to depend on the cell type and environmental conditions. Future studies are necessary at this point.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353876     DOI: 10.1016/B978-0-12-385961-7.00004-4

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  8 in total

1.  Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease.

Authors:  Wanli Ma; Weihong Han; Peter A Greer; Rubin M Tuder; Haroldo A Toque; Kevin K W Wang; R William Caldwell; Yunchao Su
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 2.  Thirty years of intracrinology.

Authors:  Richard N Re
Journal:  Ochsner J       Date:  2014

3.  Noncanonical Activin A Signaling in PC12 Cells: A Self-Limiting Feedback Loop.

Authors:  Jiao-Qi Wang; Wen-Zhao Liang; Yang Cui; Jin-Ting He; Hong-Yu Liu; Yue Wang; Long-Xing Xue; Qiu-Ye Ji; Wei Shi; Yan-Kun Shao; Jing Mang; Zhong-Xin Xu
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

Review 4.  Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion.

Authors:  Holli A Loomans; Claudia D Andl
Journal:  Cancers (Basel)       Date:  2014-12-30       Impact factor: 6.639

5.  Activin A-Smad Signaling Mediates Connective Tissue Growth Factor Synthesis in Liver Progenitor Cells.

Authors:  Ze-Yang Ding; Guan-Nan Jin; Wei Wang; Yi-Min Sun; Wei-Xun Chen; Lin Chen; Hui-Fang Liang; Pran K Datta; Ming-Zhi Zhang; Bixiang Zhang; Xiao-Ping Chen
Journal:  Int J Mol Sci       Date:  2016-03-22       Impact factor: 5.923

6.  Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells.

Authors:  Holli A Loomans; Shanna A Arnold; Laura L Quast; Claudia D Andl
Journal:  BMC Cancer       Date:  2016-11-09       Impact factor: 4.430

7.  Activin a promotes myofibroblast differentiation of endometrial mesenchymal stem cells via STAT3-dependent Smad/CTGF pathway.

Authors:  Zhenzhen Zhang; Jing Wang; Yabing Chen; Luxuan Suo; Huixian Chen; Li Zhu; Guiping Wan; Xiaodong Han
Journal:  Cell Commun Signal       Date:  2019-05-17       Impact factor: 5.712

8.  Endogenous protection derived from activin A/Smads transduction loop stimulated via ischemic injury in PC12 cells.

Authors:  Jing Mang; Chun-Li Mei; Jiao-Qi Wang; Zong-Shu Li; Ting-Ting Chu; Jin-Ting He; Zhong-Xin Xu
Journal:  Molecules       Date:  2013-10-17       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.